GB0811715D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB0811715D0 GB0811715D0 GBGB0811715.2A GB0811715A GB0811715D0 GB 0811715 D0 GB0811715 D0 GB 0811715D0 GB 0811715 A GB0811715 A GB 0811715A GB 0811715 D0 GB0811715 D0 GB 0811715D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01098—Histone deacetylase (3.5.1.98), i.e. sirtuin deacetylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0811715.2A GB0811715D0 (en) | 2008-06-26 | 2008-06-26 | Therapeutic agents |
PCT/IB2009/006274 WO2009156853A2 (en) | 2008-06-26 | 2009-06-26 | Compounds, compositions, and methods useful for modulating the expression of histone deacetylase (hdac) gene expression and/or activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0811715.2A GB0811715D0 (en) | 2008-06-26 | 2008-06-26 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0811715D0 true GB0811715D0 (en) | 2008-07-30 |
Family
ID=39683199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0811715.2A Ceased GB0811715D0 (en) | 2008-06-26 | 2008-06-26 | Therapeutic agents |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0811715D0 (en) |
WO (1) | WO2009156853A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023122535A2 (en) * | 2021-12-20 | 2023-06-29 | DNARx | Nucleic acid expression using subcutaneous administration |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008030239A1 (en) * | 2006-09-05 | 2008-03-13 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF HISTONE DEACETYLASE (HDAC) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
EP1582585A4 (en) * | 2002-12-27 | 2006-06-07 | Astellas Pharma Inc | Method of selecting novel immunosuppressant |
WO2006012222A2 (en) * | 2004-06-25 | 2006-02-02 | The J. David Gladstone Institutes | Methods of treating smooth muscle cell disorders |
WO2007070483A2 (en) * | 2005-12-12 | 2007-06-21 | The University Of North Carolina At Chapel Hill | Micrornas that regulate muscle cell proliferation and differentiation |
-
2008
- 2008-06-26 GB GBGB0811715.2A patent/GB0811715D0/en not_active Ceased
-
2009
- 2009-06-26 WO PCT/IB2009/006274 patent/WO2009156853A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009156853A2 (en) | 2009-12-30 |
WO2009156853A3 (en) | 2010-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0811304D0 (en) | Therapeutic agents | |
GB0811643D0 (en) | New therapeutic agents | |
GB0908957D0 (en) | Therapeutic agents | |
GB0819593D0 (en) | Therapeutic agents | |
HRP20130041T8 (en) | Therapeutic agents | |
GB0821693D0 (en) | Therapeutic agents | |
GB0723747D0 (en) | Therapeutic agents | |
GB0812309D0 (en) | Therapeutic agents | |
GB0805818D0 (en) | Therapeutic agents | |
GB0801080D0 (en) | Therapeutic agents | |
GB0801081D0 (en) | Therapeutic agents | |
GB0724340D0 (en) | Novel Therapeutic Agents | |
EP2454276A4 (en) | Therapeutic agents | |
GB0723748D0 (en) | Therapeutic agents | |
GB0811715D0 (en) | Therapeutic agents | |
GB0910493D0 (en) | Therapeutic agents | |
GB0820275D0 (en) | Therapeutic agents | |
GB0812563D0 (en) | Therapeutic agents | |
GB0812558D0 (en) | Therapeutic agents | |
GB0815177D0 (en) | Therapeutic agents | |
GB0801082D0 (en) | Therapeutic agents | |
GB0815765D0 (en) | New therapeutic agents | |
GB0723751D0 (en) | Therapeutic agents | |
GB0723749D0 (en) | Therapeutic agents | |
GB0725030D0 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |